Erythropoietin depletion and anaemia in diabetes mellitus

Diabetic Medicine

Volumn 16, Issue 10, 1999, Pages 813-819

  Winkler, A S ^a   Marsden, J ^a   Chaudhuri, K R ^a   Hambley, H ^a   Watkins, Peter J ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Anaemia; Autonomic neuropathy; Erythropoietin; Postural hypotension; Type 1 diabetes mellitus

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; FEMALE; HEMOGLOBIN DETERMINATION; HORMONE DEFICIENCY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ORTHOSTATIC HYPOTENSION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; ALBUMINURIA; ANEMIA; AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS; MIDDLE AGED; PROTEINURIA;

EID: 0012235757     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00172.x     Document Type: Article

References (40)

1. 1 Krantz SB, Sawyer ST, Sawada KI. The role of erythropoietin in erythroid cell differentiation. In Koch KM, Kühn K, Nonnast-Daniel B, Scigalla P. eds. Treatment of Renal Anaemia with Recombinant Erythropoietin. Contributions to Nephrology, Vol 66. London: Karger, 1988: 25-38.
2. 2 Fried W, Plzak LF, Jacobson LO, Goldwasser E. Studies on erythropoiesis III. Factors controlling erythropoietin production. Proc Soc Exp Biol Med 1954; 94: 237-241.
3. 3 Schuster SJ, Koury ST, Bohrere M, Salceda S, Caro J. Cellular sites of extra-renal and renal erythropoietin production in anaemic rats. Br J Haematol 1992; 81: 153-159.
4. 4 Caro J, Brown S, Miller O, Murray T, Erslev AJ. Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 1979; 93: 449-458.
5. 5 Eschbach JW, Adamson JW. Modern aspects of pathophysiology in renal anaemia. In Koch KM, Kühn K, Nonnast-Daniel B, Scigalla P. eds. Treatment of Renal Anaemia with Recombinant Erythropoietin Contributions to Nephrology, Vol 66. London: Karger, 1988: 63-71.
6. 6 MacDougall IC. Treatment of renal anaemia with recombinant human erythropoietin. Curr Opin Nephrol Hypertens 1992; 1: 210-219.
7. 7 Takaku F, Hirashima K, Okinaka S. Effect of bilateral section of the splanchnic nerve on eryrhropoiesis. Nature 1961; 191: 500-501.
8. 8 Beynon G. The influence of the autonomic nervous system in the control of erythropoietin secretion in the hypoxic rat. J Physiol 1977; 266: 347-360.
9. 9 Fink GD, Fisher JW. Stimulation of erythropoiesis by beta adrenergic agonists. II. Mechanism of action. J Pharmacol Exp Ther 1977; 202: 199-208.
10. 10 Zivny J, Ostadal B, Neuwirt J, Prochazka J, Pelouch V. Effect of beta adrenergic blocking agents on erythropoiesis in rats. J Pharmacol Exp Ther 1983; 226: 222-225.
11. 11 Matthews MR. Autonomic ganglia in multiple system atrophy and pure autonomic failure. In Bannister R, Mathias CJ. eds. Autonomic Failure: A Textbook of Disorders of the Autonomic Nervous System. 3rd edn. Oxford: Oxford University Press, 1992: 593-621.
12. 12 Van Ingelghem E, van Zandijcke M, Lammens M. Pure autonomic failure: a new case with clinical, biochemical and necropsy data. J Neurol Neurosurg Psychiatry 1994; 57: 745-747.
13. 13 Biaggioni I, Robertson D, Krantz S, Jones M, Haile V. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Intern Med 1994; 121: 181-186.
14. 14 Ando Y, Asahara K, Obayashi K. Autonomic dysfunction and anemia in neurological disorders. J Auton Nerv Syst 1996; 61: 145-148.
15. 15 Guy RJC, Richards F, Edmonds ME, Watkins PJ. Diabetic autonomic neuropathy and iritis: an association suggesting an immunological cause. Br Med J 1984; 189: 343-345.
16. 16 Cotes PM, Brozovic B. Diurnal variation of serum immunoreactive erythropoietin in normal subjects. Clin Endocrinol 1982; 17: 419-422.
17. 17 Ewing DJ, Campbell IW, Clarke BF. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med 1980; 92: 308-311.
18. 18 Mathias CJ, Bannister R. Investigation of autonomic disorders. In Bannister R, Mathias CJ. eds. Autonomic Failure A Textbook of Disorders of the Autonomic Nervous System, 3rd edn. Oxford: Oxford Universiry Press, 1992: 255-290.
19. 19 Page MM, Watkins PJ. The heart in diabetes: autonomic neuropathy and cardiomyopathy. In Tattersall R. eds. Clinics in Endocrinology and Metabolism. London: W.B. Saunders, 1977: 377-388.
20. 20 American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. In Robertson D, Low PA, Polinsky RJ, eds. Primer on the Autonomic Nervous System, 1st edn. San Diego: Academic Press, 1996: 334-336.
21. 21 International Committee for Standardization in Haematology. Recommended methods for measurement of red-cell and plasma volume. J Nucl Med 1988; 21: 793-800.
22. 22 Hoeldtke RD, Streeten DHP. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993; 329: 611-615.
23. 23 Fink GD, Paulo LG, Fisher JW. Effects of β-adrenergic blocking agents on erythropoietin production in rabbits exposed to hypoxia. J Pharmacol Exp Ther 1995; 193: 176-781.
24. 24 Spannhake EW, Fisher JW. Partial inhibition of hypoxia induced erythropoietin production by cholinergic blockade in the dog. Proc Soc Exp Biol Med 1977; 156: 19-23.
25. 25 Radtke HW, Claussner A, Erbes PM, Scheuermann EH, Schoeppe W, Koch KM. Serum erythropoietin in chronic renal failure: relationship to degree of anaemia and excretory renal function. Blood 1979; 54: 877-884.
26. 26 Chandra M, Clemons GK, McVicar MI. Relation of serum erythropoietin levels to renal excretory function: evidence of a lowered set point for erythropoietin production in chronic renal failure. J Pediatr 1988; 113: 312-315.
27. 27 De Klerk G, Rosengarten PCJ, Vet RJWM, Goudsmit R. Serum erythropoietin (ESF) titers in anemia of chronic renal failure. J Lab Clin Med 1982; 100: 720-734.
28. 28 Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996; 39: 1569-1576.
29. 29 Inomata S, Itoh M, Imai H, Sato T. Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy. Nephron 1997; 75: 426-430.
30. 30 Rarick MU, Espina BM, Colley DT, Chrusoskie A, Gandara S, Feinstein DI. Treatment of a unique anemia in patients with DM with epoetin alfa. Diab Care 1998; 21: 423-426.
31. 31 Garnick MB, Abels RI, Rudnick SA, Raritan NJ. The role of recombinant human erythropoietin in the management associated with acquired immunodeficiency syndrome. In Gurland HJ, Moran J, Samtleben W, Scigalla P, Wieczorek L. eds. Erythropoietin in Renal and Non-Renal Anemias. Update on Basic Research and Clinical Applications. Contributions to Nephrology, Vol 88. London: Karger, 1991: 282-293.
32. 32 Birgegard G, Gudbjörnsson B, Hällgren R, Wide L. Anemia of chronic inflammatory arthritides: Treatment with recombinant erythropoietin. In Gurland HJ, Moran J, Samtleben W, Scigalla P, Wieczorek L. eds. Erythropoietin in Renal and Non-Renal Anemias. Update on Basic Research and Clinical Applications. Contributions to Nephrology, Vol 88. London: Karger, 1991: 282-293.
33. 33 Means RT Jr, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992; 80: 1639-1647.
34. 34 Pratt MC, Lewis-Barned NJ, Walker RJ, Bailey RR, Shand BI, Livesey J. Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers. Br J Clin Pharmac 1992; 34: 363-365.
35. 35 Eschbaeh JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anaemia of end-stage renal disease with recombinant human erythropoietin: results of a combined Phase I and II clinical trial. N Engl J Med 1987; 316: 73-78.
36. 36 Ersley AJ. Erythropoietin. N Engl J Med 1991; 19: 1339-1344.
37. 37 Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ et al. Recomhinant human erythropoietin in the treatment of the anaemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Ann Intern Med 1992; 117: 739-748.
38. 38 Oster W, Herrmann F, Gamm H, Zeile G, Lindemann A, Muller G et al. Erythropoietin for the treatment of anaemia of malignancy associated with neoplastic bone marrow infiltration. J Clin Oncol 1990; 8: 956-962.
39. 39 Martin W, Smith JA, White DG. The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Br J Pharmacol 1996; 89: 563-571.
40. 40 Jandeleit K, Heintz B, Gross-Heitfeld E, Kindler J, Sieberth HG, Kirsten R et al. Increased activity of the autonomic nervous system and increased sensitivity to angiotensin II infusion after therapy with recombinant human erythropoietin [Letter]. Nephron 1990; 56: 220-221.